Skip to main navigation
Skip to content
Corcept Corcept
Main Menu
  • Contact Us
  • About
    • About Corcept
    • Board of Directors
    • Executive Team
    • Educational Grants
    • Contact Us
  • Product
    • Korlym® for Cushing's Syndrome
    • Medical Information Request
  • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigator-Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Working at Corcept
    • Benefits
    • Testimonials
    • Current Opportunities

Corporate Governance

Home - Investor Relations - Corporate Governance

Corporate Governance

Governance Documents
Corporate Governance Guidelines
Code of Ethics
Committee Charters
Compensation Committee Charter
Corporate Governance and Nominating Committee Charter
Audit Committee Charter
California Compliance
California Comprehensive Compliance Policy and Annual Declaration of Compliance Notice

Shareholder Tools

Email Alerts
Print Page
RSS Feeds

Footer Menu

  • About
    • Executive Team
    • Board of Directors
    • Educational Grants
    • Contact Us
  • Product
    • Korlym for Cushing's Syndrome
    • Medical Information Request
    • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigators Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Benefits
    • Testimonials
    • Current Opportunities
©  2021 Corcept
  • Privacy Policy
  • Terms of Use
  • Site Map